- Home
- IMXI vs PRQR Comparison
IMXI vs PRQR Comparison
Compare IMXI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- PRQR
- Stock Information
- Founded
- IMXI 1994
- PRQR 2012
- Country
- IMXI United States
- PRQR Netherlands
- Employees
- IMXI N/A
- PRQR N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- PRQR Health Care
- Exchange
- IMXI Nasdaq
- PRQR Nasdaq
- Market Cap
- IMXI 302.5M
- PRQR 244.4M
- IPO Year
- IMXI N/A
- PRQR 2014
- Fundamental
- Price
- IMXI $9.38
- PRQR $2.10
- Analyst Decision
- IMXI Buy
- PRQR Strong Buy
- Analyst Count
- IMXI 7
- PRQR 8
- Target Price
- IMXI $19.60
- PRQR $8.88
- AVG Volume (30 Days)
- IMXI 328.5K
- PRQR 205.2K
- Earning Date
- IMXI 08-15-2025
- PRQR 08-07-2025
- Dividend Yield
- IMXI N/A
- PRQR N/A
- EPS Growth
- IMXI 1.60
- PRQR N/A
- EPS
- IMXI 1.70
- PRQR N/A
- Revenue
- IMXI $652,547,000.00
- PRQR $20,129,184.00
- Revenue This Year
- IMXI N/A
- PRQR N/A
- Revenue Next Year
- IMXI $2.93
- PRQR N/A
- P/E Ratio
- IMXI $5.42
- PRQR N/A
- Revenue Growth
- IMXI N/A
- PRQR 8.65
- 52 Week Low
- IMXI $8.58
- PRQR $1.07
- 52 Week High
- IMXI $22.37
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- IMXI 42.96
- PRQR 48.29
- Support Level
- IMXI $8.58
- PRQR $2.16
- Resistance Level
- IMXI $9.57
- PRQR $2.15
- Average True Range (ATR)
- IMXI 0.34
- PRQR 0.13
- MACD
- IMXI 0.03
- PRQR -0.03
- Stochastic Oscillator
- IMXI 47.18
- PRQR 27.63
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.